OVERVIEW
This issue contains a review on the effectiveness of duplex ultrasound for detecting renal artery stenosis, a review of the supra-aortic trunks in the evaluation of ischemic strokes, a review on arteriovenous fistula stenosis, various abstracts selected for the SVU 2023 Annual Conference, a review on acquired uterine arteriovenous malformations and embolization treatment, and a report on the utilization of deep vein arterialization for limb salvage.

LEARNING OBJECTIVES
After reading and studying the papers used for CME in the March 2024 Issue of the Journal for Vascular Ultrasound, participants will be able to:

1. State the gold standard for the diagnosis of renal artery stenosis.
2. State the condition associated with fibromuscular dysplasia in children.
3. List the ultrasound characteristics used to access renal artery stenosis.
4. Define positive predictive value.
5. Explain the advances in diagnostic ultrasound over the years.
6. List risk factors that correlate with ischemic stroke.
7. State the second leading cause of death and disability in the world.
8. State the volume flow associated with an increased risk of arteriovenous fistula thrombus.
9. Explain the methods used to measure intimal medial thickness.
10. Describe the ultrasound characteristics of a venous stenosis.
11. List the complications associated with an upper extremity arterial aneurysm.
12. Explain the non-invasive use of vascular elastography.
13. State the characteristics of Lemierre’s syndrome.
14. Explain the usefulness of intravascular lithotripsy in patients with vascular disease.
15. List the imaging modalities used to diagnose a uterine arteriovenous malformation.
16. Explain the treatment options for a uterine arteriovenous malformation.
17. List the ultrasound characteristics of an arteriovenous malformation.
18. State the Rutherford category for critical limb ischemia.
19. Explain how a deep vein arterialization is surgically created.
20. List complications associated with deep vein arterialization.

TARGET AUDIENCE
Physician, Vascular Technologist and Sonographer members of SVU should find participating in this educational activity valuable.
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Society for Vascular UltrasoundThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Cincinnati designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OFF-LABEL DISCLOSURE STATEMENT
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

LEARNER ASSURANCE STATEMENT
The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

DISCLAIMER STATEMENT
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.